Deadline to participate in the next selection round: December 17, 2018

CQDM’s SynergiQc program is designed to promote university-based industrial research in the biopharmaceutical field that will generate economic benefits for Quebec.

Deadline to participate in the next selection round (full application): December 17, 2018

Note to researchers applying for SynergiQc funding with a project focusing on breast cancer: 

As part of the  SynergiQc program, CQDM has partnered with the Canadian Cancer Society (CCS) to fund research focusing on the prevention, diagnosis and treatment of breast cancer. As a result, additional funds of $4M will be made available to the SynergiQc program to support research projects targeting breast cancer.

The deadline to submit an application is December 17, 2018.

For more details, please refer to: Call for Proposals for CQDM/CCS SynergiQc on Breast Cancer

Please contact Marc Thibault at 514-766-6661, ext. 2190, before submitting this form: Application Form for CQDM/CCS SynergiQc on Breast Cancer 

SCOPE AND RESEARCH AGENDA
Scope and research agenda of the Quebec Funding Program for Biopharmaceutical Research

SynergiQC is a Quebec funding program for biopharmaceutical research created by CQDM. It is designed to promote university-based industrial research in the biopharmaceutical field that will generate economic benefits across Quebec.

With the Quebec funding program for biopharmaceutical research, CQDM extends is funding capacity to the development of biopharmaceutical products with high industrial and commercial value, such as more competitive molecules and other technologies that support a larger number of companies by expanding its pool of industrial members.

SynergiQc offers a large network of life sciences organizations (pharmas, SMEs, spin-offs and start-up, CROs, etc.) the opportunity to fund, individually or collectively, academic projects in Quebec that address their specific needs.

This industrial biopharmaceutical research program specifically aims to:

  • Promote the technological innovation capabilities of Quebec businesses by tapping into academic research.
  • Increase collaborations and partnerships across Quebec universities and companies in the life sciences industry.
  • Foster technological maturation and industrial value creation benefiting project stakeholders and Quebec as a whole.
  • Promote the knowledge, know-how, and new technologies developed in public institutions and help with their transfer to the industry.
ELIGIBILITY CRITERIA
Eligibility criteria of the Quebec Funding Program for Biopharmaceutical Research

Eligible applicants

  • Scientists working in academic research institutions in Quebec (universities and affiliated hospitals, research institutes, and College Centres for Technology Transfer [CCTT]) working in close collaboration with one or more life sciences organizations:
    • Such organizations include entities (private or public company, foundation, etc.) dedicating non-government funds to the project. At least one of these organizations must have R&D or manufacturing activities in Quebec.

Eligible projects and criteria:

  • Industrially oriented academic research projects conducted in partnership with one or more organizations are eligible.
  • Socio-economic benefits must be generated for the province of Quebec and for private partners participating in each project.
  • Applicants are responsible to ensure that the financial structure for the project meet the program criteria (refer to the Financing section for details on the required matching funds).
  • CQDM can assist applicants with this step, as detailed in the Application Submission Process section.
  • Two categories of biopharmaceutical research projects are eligible, based on the Technology Readiness Level (TRL). The TRL is determined at the beginning of the project (refer to the TRL Guide here):
    • Project TRL ranging from 1 to 3: involves a minimum of two private organizations, with at least one with internal research and development (R&D) and/or production activities in Quebec, as well as at least one Quebec academic research institution.
    • Project TRL ranging 4 to 6: involves a minimum of one Quebec-based organization engaging in internal research and development (R&D) or production, and at least one Quebec university, CCTT or public research centre.
FUNDING
Funding of the Quebec Funding Program for Biopharmaceutical Research

Duration

Minimum 1 year, maximum 3 years

Funding details

The CQDM will consider applications for large-scale projects that can generate significant economic benefits for their stakeholders.

Minimum budget: each project must have a budget of no less than $500k; exceptions may be considered by demonstrating that significant value can be created with a smaller budget.

Maximum budget: $3.75M for TRL 1-3 projects and $7.5M for TRL 4-6 projects.

Budget details will be carefully examined and must be well documented.

Technology readiness level (TRL) 1-3 projects:

  • CQDM’s financial support represents a maximum of 40% of eligible costs.
  • At least two private partners must fund a minimum of 20 % of eligible research project costs, in cash, with at least one with research and development and/or manufacturing activities in Quebec.
  • Canadian and foreign companies, as well as foundations can qualify as the second private partner.

Technology readiness level (TRL) 4-3 projects:

  • CQDM’s financial support may represent up to 20% of eligible costs.
  • partner organization must fund a minimum of 40% of eligible research project costs. No less than 50% of private contributions must be in cash, while the remaining amount can be a contribution in kind, if properly justified.

For more information on funding scenarios for each TRL, please refer to Table 1 below.

Table 1. Summary of funding scenarios

Characteristics

TRL 1-3

TRL 4-6

CQDM’s maximum contribution

40 % of eligible costs or 50% of eligible costs with the involvement of a sector-focused industrial research community

Maximum: $500k per year ($1.5M over 3 years).

20% of eligible costs

Maximum: $500k per year ($1.5M over 3 years).

Number of private partner organizations required

At least two (2), with one engaged in research or manufacturing in Quebec.

At least one (1) engaged in research or manufacturing in Quebec.

Contribution required by private partner organizations

20% to 60% of the project’s eligible expenses in cash 


One single partner cannot provide more than 80% of the amount contributed by all private partner organizations.

40% to 80% of the project’s eligible costs

Contributions in kind cannot exceed 20% of total project costs.

Other matched funding*

Combined support from government agencies cannot exceed 80% of total project costs.

Combined support from government agencies cannot exceed 80% of total project costs.

* Combined government support (municipal, provincial, and federal) including contributions from public partners (associations, organizations, etc.) cannot exceed 80% of total project costs. In such cases, CQDM funding will be reduced by a percentage equivalent to the excess funding.

Indirect research costs (IRCs) will be added to total project costs: a fixed rate of 27% for IRCs will be applied to eligible expenditure items associated with the funds provided by the MESI (Ministère de l’Économie, de la Science et de l’Innovation). IRCs (wages and fringe benefits, fellowships, equipment and supplies) are excluded from the partner contribution ratios described in Table 1.

For detailed examples of funding scenarios, please refer to Table 2 and Table 3 here.

ELIGIBLE COSTS
Eligible costs of the Quebec Funding Program for Biopharmaceutical Research

Fellowships, wages and fringe benefits for research personnel assigned to the project (technicians, research assistants and associates, postdoctoral fellows, and students).

  • Laboratory material and fees paid to third parties required to execute the project.
  • Travel expenses (travel related to the project, collaborations, conferences) and knowledge dissemination costs.
  • Intellectual property costs (patent applications, patent maintenance fees for the duration of the project).

Only expenses incurred by public institutions are eligible.

Non-eligible costs:

  • Equipment purchases and rental (or purchase) of facilities.
  • Salary of the principal investigator (PI) and co-investigators from universities and their affiliated research centers.
APPLICATION PROCESS
Application process of the Quebec Funding Program for Biopharmaceutical Research

Call for proposals are open year-round for SynergiQc projects.

Deadline to participate in the next selection round:

December 17, 2018

 Application process:

  1. Prepare a half-page, non-confidential scientific summary and send it to  Marc Thibault, Director of Business Development, at least 10 days before proceeding to the next step.
  2. Complete the SynergiQc Application Form.
  3. Include the letters of support from partner organizations in the appendix.
  4. Applications must be submitted electronically through CQDM’s secure site (https://cqdm.firmex.com). To obtain a username or password, or for questions, please contact the above stated team member.

We strongly recommend contacting Marc Thibault, Director of Business Development, at 514-766-6661 ext. 2190, for questions or assistance regarding the program, including budgeting and funding arrangements.

SELECTION CRITERIA
Selection criteria of the Quebec Funding Program for Biopharmaceutical Research

  • Scientific excellence, the innovative nature of the project, its contribution to science, and the quality and relevance of the proposed methodology in relation to the final product.
  • The project’s feasibility, the soundness of the research plan and of the proposed budget.
  • The competitive advantage of the proposed technology.
  • The creation of industrial value and the compatibility of the project with partner needs.
  • The degree of financial involvement of the partner.
  • The synergy between researchers and complementarity of their expertise in executing the project.
  • The soundness of the development and technology maturation plan with a clear path for deployment to end users.
  • The economic benefits for Quebec and the private partners.
  • The training of a specialized and high-quality workforce.
EVALUATION PROCESS
Evaluation process of the Quebec Funding Program for Biopharmaceutical Research

Key  evaluation steps:

  • An independent scientific evaluation based on the selection criteria detailed above.
  • An evaluation of non-scientific aspects of the project, including the quality of the relationship and cooperation between the researchers and organizations, the added value of the collaboration, and the economic benefits for each of the stakeholders, including for Quebec.
  • Funding recommendations by CQDM’s Scientific Advisory Board and its recommendation to CQDM’s Board of Directors.

CQDM Board approval.

RESEARCH AGREEMENT AND INTELLECTUAL PROPERTY POLICY
Research agreement associated with the Quebec Funding Program for Biopharmaceutical Research

  • Researchers who will be awarded a research grant from CQDM will be required to sign a research agreement within 3 months after receiving the funding confirmation letter. The research agreement must be signed by all research organizations involved in the project, including private partners.
  • CQDM will provide a draft research agreement based on the following principles:
  • Researchers retain intellectual property rights, in compliance with the policies of research organizations associated with the project.
  • The research agreement includes specific project milestones, timelines (Gantt chart) and deliverables.
  • Any inter-institutional intellectual property agreement signed by all research organizations involved in the project and to which CQDM is not party must be included in the research agreement as an appendix.